E-health for Self-Management of Chronic Pain

February 10, 2023 updated by: Lund University

Self-Management of Chronic Pain Using a Digital Pain-Management Tool.

The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.

Study Overview

Status

Completed

Conditions

Detailed Description

Chronic pain is today an increasing health problem in both Europe and US, with an estimation of about 90 million people affected in Europe (Breivik, H. et al., 2006) and 100 million people in US (Relieving Pain in America, IOM Report 2011), or 20-30% of the adult population around the world. Chronic pain is defined as a condition that lasts for at least three to six months, after the normal healing period of an injury. Medical interventions offered in clinics around the globe are unfortunately not giving the results needed to give back the quality of life the patients had prior to the onset of the pain. The treatments offered today do sometimes reduce pain, but the effect is minor, and new treatment regimens are needed (Relieving Pain in America, 2011). Recent quality assurance registry measurements in Sweden has shown that patient taken part of multi modal treatment regimens, such as the acceptance and commitment therapy, (ACT) show that less then 40% of the patients have a decline in the pain level of 1 level on the VAS scale, 55% has no effect and 9 % has an increased level of pain after going through the program (Nationel Register for Pain Rehabilitation, Sweden 2017)

The study objective is to evaluate how the use of a digital pain coach, based on artificial intelligence that improves the self-management of pain will decrease the pain interference and thereby increase QoL among chronic pain patients, as measured by PROMIS pain interference 6a. We will here compare the improvement of quality of life by a decrease in pain interference, measured by PROMIS, in patients who follow their traditional treatment plan provided by the Pain Clinic with the addition of using a web application for increased self management of pain. The theory behind the study and the development of the device is supported by previously known data, showing that self-management has an effect and is important to the treatment by helping patients to believe in their own capacity to control their pain.

The present investigation aims at exploring the effect of including a digital tool as an add on to standard treatment and rehabilitation and will measure the effect it has on:

  1. Decreased pain interference
  2. Improved management of long-term pain and its consequences. Hence self-management of pain
  3. Increased function in daily life with the best possible activity and participation level
  4. Improved experience of health-related quality of life
  5. Decreased pain experience

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10065
        • Weill Cornell Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults with chronic pain patients at the Joan and Sanford I. Weill Medical College of Cornell University - A specialist clinic for pain therapy.

Description

Inclusion Criteria:

  • Have a complex, prolonged axial neck pain or lower back pain
  • Have been followed by a pain management specialist for at least 3 months or have a history of chronic pain for at least 3 months as recorded by physician
  • Be >18 years of age
  • Have a goal and motivation that is adequate in relation to the program offered
  • Be medically prepared
  • Have no major change in interventional treatment or be a surgical candidate
  • Own a smart phone, tablet or computer or have the knowledge to use one

Exclusion Criteria:

  • Chronic pain requiring imminent surgical intervention
  • Reported severe or acute psychiatric illness, severe anxiety or depression
  • Current history of substance abuse
  • Serious health risks or scheduled major health interventions for other medical reasons
  • Pain related to malignancy
  • Pain duration <3 months
  • Other areas of pain exceeding the amount of back or neck pain
  • Not currently involved in lawsuit or pending litigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain interference
Time Frame: 6 and 12 weeks from baseline

Change from baseline in pain interference (QoL), measured by PROMIS Pain Interference 6a .

Measure of the amount of interference pain causes in life; range 6-30; higher is worse

6 and 12 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain severity
Time Frame: 6 and 12 weeks from baseline
Change from Baseline in the 7 day average pain intensity. Measured by NRS using an 11-point Pain Intensity Numerical Rating Scale (NRS) (0=no pain, 10=pain as bad as you can imagine)
6 and 12 weeks from baseline
Physical function
Time Frame: 6 and 12 weeks from baseline

Change from baseline in physical function, measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Physical function 10a.

Measure of the impact of a condition on physical function; range 4-20; higher is worse

6 and 12 weeks from baseline
Depression
Time Frame: 6 and 12 weeks from baseline

Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression 4a.

Measures the extent to which patients experience depressive symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of depression

6 and 12 weeks from baseline
Anxiety
Time Frame: 6 and 12 weeks from baseline

Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Anxiety 4.

Measures the extent to which patients experience anxiety symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of anxiety.

6 and 12 weeks from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Neel Metha, MD, Weill Cornell Medicine, Department of Anesthesiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2021

Primary Completion (ACTUAL)

May 1, 2022

Study Completion (ACTUAL)

June 1, 2022

Study Registration Dates

First Submitted

November 10, 2020

First Submitted That Met QC Criteria

November 12, 2020

First Posted (ACTUAL)

November 13, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2023

Last Update Submitted That Met QC Criteria

February 10, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Digital Pain-Management Tool

Subscribe